Inhibition of mast cell histamine release by specific phosphodiesterase inhibitors.
Lau
H Y A
HY
Department of Pharmacology, Faculty of Medicine, Basic Medical Sciences Building, Chinese University of Hong Kong, Shatin, New Territories, Hong Kong SAR, PR China. hyalau@cuhk.edu.hk
Kam
M F A
MF
D012368:4-(3-Butoxy-4-methoxybenzyl)-2-imidazolidinone / Q000494:pharmacology; D000818:Animals; D006146:Guanidines / Q000494:pharmacology; D006632:Histamine / Q000378:metabolism*; D008407:Mast Cells / Q000187:drug effects* / Q000201:enzymology / Q000378:metabolism*; D010726:Phosphodiesterase Inhibitors / Q000494:pharmacology*; D010727:Phosphoric Diester Hydrolases / Q000378:metabolism*; D020033:Protein Isoforms / Q000037:antagonists & inhibitors / Q000378:metabolism; D011724:Pyridazines / Q000494:pharmacology; D051381:Rats; D017207:Rats, Sprague-Dawley; D020889:Rolipram / Q000494:pharmacology
D006146:Guanidines; D010726:Phosphodiesterase Inhibitors; D020033:Protein Isoforms; D011724:Pyridazines; D012368:4-(3-Butoxy-4-methoxybenzyl)-2-imidazolidinone; C056215:siguazodan; D006632:Histamine; D010727:Phosphoric Diester Hydrolases; D020889:Rolipram